The scientist’s investigation covers issues in Virology, Hepatitis B virus, HBsAg, Virus and Antibody. His Virology research incorporates themes from Epitope, Immunology and Antigen. His is involved in several facets of Hepatitis B virus study, as is seen by his studies on Hepadnaviridae and Orthohepadnavirus.
His HBsAg research is multidisciplinary, incorporating perspectives in Hepatitis B, Molecular biology, Vaccination and Polyclonal antibodies. His biological study spans a wide range of topics, including Nucleic acid sequence and Reverse transcriptase. His Antibody research includes elements of Cancer research, Primary biliary cirrhosis, Lymph node, Serial passage and Ductopenia.
His main research concerns Virology, Hepatitis B virus, Immunology, Virus and Hepatitis B. His work carried out in the field of Virology brings together such families of science as Epitope, Antibody and Antigen. The various areas that he examines in his Hepatitis B virus study include Vaccination and Hepatitis.
As a part of the same scientific study, William F. Carman usually deals with the Immunology, concentrating on Transplantation and frequently concerns with Hepatitis B immune globulin. William F. Carman has included themes like Multiplex and Polymerase chain reaction in his Virus study. His Hepatitis B study incorporates themes from Hepacivirus, Hepatitis C virus, Viral hepatitis, Family medicine and Alpha interferon.
His primary areas of investigation include Virology, Immunology, Virus, Pandemic and Influenza A virus. His study in Virology concentrates on Vaccination and Hepatitis B virus. His studies in Hepatitis B virus integrate themes in fields like Hepatitis B, Viral hepatitis, Fulminant hepatitis, Clinical significance and Promoter.
His Immunology study combines topics from a wide range of disciplines, such as Young adult and Incidence. The study incorporates disciplines such as Immunoassay and Antibody in addition to Virus. His research investigates the link between Influenza A virus and topics such as Influenza A virus subtype H5N1 that cross with problems in Typing, Viral load, Cellular Immunology and Infection control.
William F. Carman mainly investigates Virology, Immunology, Pandemic influenza, Influenza A virus and Human mortality from H5N1. In the field of Virology, his study on Hepatitis B virus, Hepatitis b surface antigen and Hepatitis B antibody overlaps with subjects such as Proinflammatory cytokine. His work in Hepatitis B virus covers topics such as Hepatitis C virus which are related to areas like Hepatitis C.
His Immunology research incorporates themes from Diagnostic dilemma and DNA polymerase. While the research belongs to areas of Influenza A virus, William F. Carman spends his time largely on the problem of Cytotoxic T cell, intersecting his research to questions surrounding Cellular immunity, Influenza vaccine and Epitope. His work deals with themes such as Immunoassay, Cellular Immunology and Cytokine, which intersect with Virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION
W.F Carman;S Hadziyannis;M.J Mcgarvey;M.R Jacyna.
The Lancet (1989)
Vaccine-induced escape mutant of hepatitis B virus
W.F. Carman;P. Karayiannis;J. Waters;H.C. Thomas.
The Lancet (1990)
Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial
William F Carman;Alexander G Elder;Lesley A Wallace;Karen McAulay.
The Lancet (2000)
Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly Patients
J. Potter;D. J. Stott;M. A. Roberts;A. G. Elder.
The Journal of Infectious Diseases (1997)
Hepatitis B vaccine
Howard Christopher Thomas;William Frederick Carman.
Dicp-The annals of pharmacotherapy (1995)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar;Shaima Begom;Alison Bermingham;Katja Hoschler.
Nature Medicine (2013)
Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region
Lieven J. Stuyver;Stephen A. Locarnini;Anna Lok;Douglas D. Richman.
Hepatology (2001)
The clinical significance of surface antigen variants of hepatitis B virus
W. F. Carman.
Journal of Viral Hepatitis (1997)
Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993–4 epidemic: results of serum testing and questionnaire
Alexander G Elder;Barbara O'Donnell;Elizabeth A B McCruden;Ian S Symington.
BMJ (1996)
Does a betaretrovirus infection trigger primary biliary cirrhosis
Lizhe Xu;Zhiwei Shen;Linsheng Guo;Brent Fodera.
Proceedings of the National Academy of Sciences of the United States of America (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Imperial College London
NHS Lothian
Athens State University
University of Nicosia
University of Strathclyde
Melbourne Health
Humanity and Health Medical Group
University of Glasgow
Imperial College London
University of Oxford
KTH Royal Institute of Technology
Curtin University
University of Massachusetts Lowell
National Taiwan University
Virginia Tech
Ulsan National Institute of Science and Technology
Dalian University of Technology
University of California, San Diego
Instituto de Salud Carlos III
University of California, Santa Cruz
University of Cologne
Tokyo University of Marine Science and Technology
University of Kansas
University of Verona
Université Paris Cité
Regeneron (United States)